---
figid: PMC5119517__nihms807767f1
figlink: /pmc/articles/PMC5119517/figure/F1/
number: F1
caption: 'Schematic of the PI3K/mTOR signaling pathway. Figure legend: upon receptor
  tyrosine kinase (RTK) stimulation, PI3K phosphorylates the lipid moiety PIP2, creating
  PIP3. AKT is recruited to the membrane, where it is phosphorylated and activated
  by the mTORC2 complex and PDK. AKT phosphorylates and inhibits the TCS complex,
  which permits the activation of mTORC1 by RHEB GTPase. The RTK pathway also actives
  the RAS-ERK pathway and feeds into TSC1/2 regulation. PTEN is a phosphatase and
  converts PIP2 back to PIP2, inhibiting PI3K signals.'
pmcid: PMC5119517
papertitle: 'Tumor mutational analysis of GOG248, a phase II study of temsirolimus
  or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial
  cancer (EC): An NRG Oncology/Gynecologic Oncology Group study.'
reftext: Andrea P. Myers, et al. Gynecol Oncol. ;141(1):43-48.
pmc_ranked_result_index: '17550'
pathway_score: 0.9481093
filename: nihms807767f1.jpg
figtitle: The PI3K/mTOR signaling pathway
year: ''
organisms: Homo sapiens
ndex: cbbceaa0-def9-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5119517__nihms807767f1.html
  '@type': Dataset
  description: 'Schematic of the PI3K/mTOR signaling pathway. Figure legend: upon
    receptor tyrosine kinase (RTK) stimulation, PI3K phosphorylates the lipid moiety
    PIP2, creating PIP3. AKT is recruited to the membrane, where it is phosphorylated
    and activated by the mTORC2 complex and PDK. AKT phosphorylates and inhibits the
    TCS complex, which permits the activation of mTORC1 by RHEB GTPase. The RTK pathway
    also actives the RAS-ERK pathway and feeds into TSC1/2 regulation. PTEN is a phosphatase
    and converts PIP2 back to PIP2, inhibiting PI3K signals.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK1
  - MAPK3
  - MAP2K1
  - RPTOR
  - MTOR
  - RICTOR
  - AKT2
  - TSC1
  - PIK3CA
  - PIK3CB
  - MAP2K2
  - PIK3CG
  - PIK3R3
  - MLST8
  - PIK3CD
  - ARAF
  - RAF1
  - AKT1
  - PTEN
  - RHEB
  - AKT3
  - MAPKAP1
  - PIK3R5
  - PIK3R4
  - NRAS
  - BRAF
  - KRAS
  - PIK3R6
  - TSC2
  - HRAS
  - temsirolimus
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: TSC1/2
  symbol: TSC1
  source: hgnc_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: RHEB
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MAPKAP1
  entrez: '79109'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: TSC1/2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
chemicals:
- word: temsirolimus
  source: MESH
  identifier: C401859
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC5119517__F1
redirect_from: /figures/PMC5119517__F1
figtype: Figure
---
